Trophic factors counteract elevated FGF-2-induced inhibition of adult neurogenesis

Neurobiology of Aging

Volumn 28, Issue 8, 2007, Pages 1148-1162

  Chen, Honghui ^a   Tung, Yunn Chyn ^a   Li, Bin ^a   Iqbal, Khalid ^a   Grundke Iqbal, Inge ^a  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

Alzheimer disease; Basic fibroblast growth factor; Cerebrolysin ; Ciliary neurotrophic factor; Glial derived neurotrophic factor; Insulin like growth factor 1; Insulin like growth factor 2; Neurogenesis; Neuronal differentiation; Neurotrophic factors; Progenitor cells

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CEREBROLYSIN; CILIARY NEUROTROPHIC FACTOR; FIBROBLAST GROWTH FACTOR 2; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; NESTIN; SOMATOMEDIN B; SOMATOMEDIN C;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DEVELOPMENT; CELL CULTURE; CELL DIVISION; CELL LINEAGE; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG TARGETING; GROWTH INHIBITION; HIPPOCAMPUS; MALE; MOUSE; NERVE CELL DIFFERENTIATION; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL;

AMINO ACIDS; ANIMALS; ANTIBODIES; BROMODEOXYURIDINE; CELL COUNT; CELL DIFFERENTIATION; CELLS, CULTURED; DRUG INTERACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBROBLAST GROWTH FACTOR 2; HIPPOCAMPUS; INTERMEDIATE FILAMENT PROTEINS; MALE; NERVE GROWTH FACTORS; NERVE TISSUE PROTEINS; NEURAL INHIBITION; NEURONS; RATS; RATS, WISTAR; STEM CELLS;

EID: 34249336353     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2006.05.036     Document Type: Article

References (68)

1. Aberg M.A., Aberg N.D., Hedbacker H., Oscarsson J., and Eriksson P.S. Peripheral infusion of IGF-1 selectively induces neurogenesis in the adult rat hippocampus. J Neurosci 20 (2000) 2896-2903
2. Albrecht P.J., Dahl J.P., Stoltzfus O.K., Levenson R., and Levison S.W. Ciliary neurotrophic factor activates spinal cord astrocytes, stimulating their production and release of fibroblast growth factor-2, to increase motor neuron survival. Exp Neurol 173 (2002) 46-62
3. Alvarez X.A., Sampedro C., Perez P., Laredo M., Couceiro V., Hernandez A., et al. Positive effects of Cerebrolysin on electroencephalogram slowing, cognition and clinical outcome in patients with post-acute traumatic brain injury: an exploratory study. Int Clin Psychopharmacol 18 (2003) 271-278
4. Alvarez X.A., Cacabelos R., Laredo M., Couceiro V., Sampedro C., Varela M., et al. A 24-week, double-blind, placebo-controlled study of three dosages of Cerebrolysin in patients with mild to moderate Alzheimer's disease. Eur J Neurol 13 (2006) 43-54
5. Anneren G., Tuvemo T., Carlsson-Skwirut C., Lonnerholm T., Bang P., Sara V.R., et al. Growth hormone treatment in young children with Down's syndrome: effects on growth and psychomotor development. Arch Dis Child 80 (1999) 334-338
6. Avila J. The influence of aging in one tauopathy: Alzheimer disease. Arch Immunol Ther Exp (Warsz) 52 (2004) 410-413
7. Ballas N., Grunseich C., Lu D.D., Speh J.C., and Mandel G. REST and its corepressors mediate plasticity of neuronal gene chromatin throughout neurogenesis. Cell 121 (2005) 645-657
8. Bensadoun A., and Weinstein D. Assay of proteins in the presence of interfering materials. Anal Biochem 70 (1976) 241-250
9. Betchen S.A., and Kaplitt M. Future and current surgical therapies in Parkinson's disease. Curr Opin Neurol 16 (2003) 487-493
10. Bonni A., Sun Y., Nadal-Vicens M., Bhatt A., Frank D.A., Rozovsky I., et al. Regulation of gliogenesis in the central nervous system by the JAK-STAT signaling pathway. Science 278 (1997) 477-483
11. Boucher S.E., and Hitchcock P.F. Insulin-related growth factors stimulate proliferation of retinal progenitors in the goldfish. J Comp Neurol 394 (1998) 386-394
12. Brickman Y.G., Ford M.D., Gallagher J.T., Nurcombe V., Bartlett P.F., and Turnbull J.E. Structural modification of fibroblast growth factor-binding heparan sulfate at a determinative stage of neural development. J Biol Chem 273 (1998) 4350-4359
13. Cameron H.A., and McKay R.D. Restoring production of hippocampal neurons in old age. Nat Neurosci 2 (1999) 894-897
14. Carro E., Trejo J.L., Gomez-Isla T., LeRoith D., and Torres-Aleman I. Serum insulin-like growth factor I regulates brain amyloid-beta levels. Nat Med 8 (2002) 1390-1397
15. Chen H., Fu Y.S., and Guo J.W. Ability of GDNF to diminish free radical production leads to protection against kainite-induced excitotoxicity in hippocampus. Hippocampus 14 (2004) 77-86
16. Cummings B.J., Su J.H., and Cotman C.W. Neuritic involvement within FGF-2 immunopositive plaques of Alzheimer disease. Exp Neurol 124 (1993) 315-325
17. Donovan M.H., Yazdani U., Norris R.E., Games D., German D.C., and Eisch A.J. Decreased adult hippocampal neurogenesis in the PDAPP mouse model of Alzheimer's disease. J Comp Neurol 495 (2006) 70-83
18. Durany N., Michel T., Jellinger K., Cruz-Sanchez F.F., Cervos-Navarro J., and Riederer P. Brain-derived neurotrophic factor and neurotrophin-3 levels in Alzheimer disease brains. Int J Dev Neurosci 18 (2000) 807-813
19. Emerich D.F., and Thanos C.G. Intracompartmental delivery of CNTF as therapy for Huntington's disease and retinitis pigmentosa. Curr Gene Ther 6 (2006) 147-159
20. Emsley J.G., and Hagg T. Endogenous and exogenous ciliary neurotrophic factor enhances forebrain neurogenesis in adult mice. Exp Neurol 183 (2003) 298-310
21. Eriksson P.S., Perfilieva E., Bjork-Eriksson T., Alborn A.M., Noedborg C., Peterson D.A., et al. Neurogenesis in the adult human hippocampus. Nat Med 4 (1998) 1313-1317
22. Ford-Perriss M., Turner K., Guimond S., Apedaile A., Haubeck H.D., Turnbull J., et al. Localisation of specific heparan sulfate proteoglycans during the proliferative phase of brain development. Dev Dyn 227 (2003) 170-184
23. Frederick T.J., and Wood T.L. IGF-1 and IGF-2 coordinately enhance cyclin D1 and cyclin E-cdk2 association and activity to promote G1 progression in oligodendrocyte progenitor cells. Mol Cell Neurosci 25 (2004) 480-492
24. Gasparini L., Gouras G.K., Wang R., Gross R.S., Beal M.F., Greengard P., et al. Stimulation of beta-amyloid precursor protein trafficking by insulin reduces intraneuronal beta-amyloid and requires mitogen-activated protein kinase signaling. J Neurosci 21 (2001) 2561-2570
25. Gould E., Beylin A., Tanapat P., Reeves A., and Shors T.J. Learning enhances adult neurogenesis in the hippocampal formation. Nat Neurosci 2 (1999) 260-265
26. Grondin R., Zhang Z., Ai Y., Gash D.M., and Gerhardt G.A. Intracranial delivery of proteins and peptides as a therapy for neurodegenerative diseases. Prog Drug Res 61 (2003) 101-123
27. Ho G.J., Drego R., Hakimian E., and Masliah E. Mechanisms of cell signaling and inflammation in Alzheimer's disease. Curr Drug Targets Inflamm Allergy 4 (2005) 247-256
28. Hock C., Heese K., Hulette C., Rosenberg C., and Otten U. Region-specific neurotrophin imbalances in Alzheimer disease. Arch Neurol 57 (2000) 846-851
29. Hockfield S., and McKay R.D. Identification of major cell classes in the developing mammalian nervous system. J Neurosci 5 (1985) 3310-3328
30. Hoffman M.C., Braydich-Stolle L., and Dym M. Isolation of male germ-line stem cells; influence of GDNF. Dev Biol 279 (2005) 114-124
31. Hong M., and Lee V.M.Y. Insulin and insulin-like growth factor-1 regulate tau phosphorylation in cultured human neurons. J Biol Chem 272 (1997) 19547-19553
32. Jin K., Peel A.L., Mao X.O., Xie L., Cottrell B.A., Henshall D.C., et al. Increased hippocampal neurogenesis in Alzheimer disease. Proc Natl Acad Sci USA 101 (2004) 343-347
33. SW,Ind) mice. Proc Natl Acad Sci USA 34 (2004) 13363-13367
34. Johe K.K., Hazel T.G., Muller T., Dugich-Djordjevic M.M., and McKay R.D.G. Single factors direct the differentiation of stem cells from fetal and adult central nervous system. Genes Dev 10 (1996) 3129-3140
35. Kaur N., Lu B., Monroe R.K., Ward S.M., and Halvorsen S.W. Inducers of oxidative stress block ciliary neurotrophic factor activation of Jak/STAT signaling in neurons. J Neurochem 92 (2005) 1521-1530
36. Kempermann G., Kuhn H.G., and Gage F.H. More hippocampal neurons in adult mice living in an enriched environment. Nature 386 (1997) 493-495
37. Kuhn H.G., Dickinson-Anson H., and Gage F.H. Neurogenesis in the dentate gyrus of the adult rat: age-related decrease of neuronal progenitor proliferation. J Neurosci 16 (1996) 2027-2033
38. Levison S.W., Ducceschi M.H., Young G.M., and Wood T.L. Acute exposure to CNTF in vivo induces multiple components of reactive gliosis. Exp Neurol 141 (1996) 256-268
39. Lesort M., and Johnson G.V.W. Insulin-like growth factor-1 and insulin mediate transient site-selective increases in tau phosphorylation in primary cortical neurons. Neuroscience 99 (2000) 305-316
40. Lindahl B., Westling C., Gimenez-Gallego G., Lindahl U., and Salmivirta M. Common binding sites for β-amyloid fibrils and fibroblast growth factor-2 in heparan sulfate from human cerebral cortex. J Biol Chem 274 (1999) 30631-30635
41. Masliah E., Armasolo F., Veinbergs J., Mallory M., and Samuel W. Cerebrolysin ameliorates performance deficits, and neuronal damage in apolipoprotein E-deficient mice. Pharmacol Biochem Behav 62 (1999) 239-245
42. Mittoux V., Joseph J.M., Conde F., Palfi S., Dautry C., Poyot T., et al. Restoration of cognitive and motor functions by ciliary neurotrophic factor in a primate model of Huntington's disease. Hum Gene Ther 11 (2000) 1177-1187
43. Morgan D., Gordon M.N., Tan J., Wilcock D., and Rojiani A.M. Dynamic complexity of the microglial activation response in transgenic models of amyloid deposition: implications for Alzheimer therapeutics. J Neuropathol Exp Neurol 64 (2005) 743-753
44. Mustafa A., Lannfelt L., Lilius L., Islam A., Winblad B., and Adam A. Decreased plasma insulin-like growth factor-I level in familial Alzheimer disease patients carrying the Swedish APP 670/671 mutation. Dement Geriatr Cogn Disord 10 (1999) 446-451
45. Nakamura Y., Yamamoto M., Oda E., Yamamoto A., Kanemura Y., Hara M., et al. Stem/progenitor cells and radial fibers during human fetal brain development. Lab Invest 83 (2003) 479-489
46. Ohkubo Y., Uchida A.O., Shin D., Partanen J., and Vaccarino F.M. Fibroblast growth factor receptor 1 is required for the proliferation of hippocampal progenitor cells and for hippocampal growth in mouse. J Neurosci 24 (2004) 6057-6069
47. Ostenfeld T., Tai Y.T., Martin P., Deglon N., Aebischer P., and Svendsen C.N. Neurospheres modified to produce glial cell line-derived neurotrophic factor increase the survival of transplanted dopamine neurons. J Neurosci Res 69 (2002) 955-965
48. Panisset M., Gauthier S., Moessler H., Windisch M., and The Cerebrolysin Study Group. Cerebrolysin in Alzheimer disease: a randomized, double-blind, placebo-controlled trial with a neurotrophic agent. J Neural Transm 109 (2002) 1089-1104
49. Raff M.C., Abney E.R., Cohen J., Lindsay R., and Noble M. Two types of astrocytes in cultures of developing rat white matter: differences in morphology, surface gangliosides, and growth characteristics. J Neurosci 3 (1983) 1289-1300
50. Ragusa L., Valetta M.R., Proto C., Alberti A., Romano C., Rossodivita A., et al. IGF-I levels in prepubertal and pubertal children with Down syndrome. Minerva Endocrinol 23 (1998) 31-36
51. Rajan P., and McKay R.D. Multiple routes to astrocytic differentiation in the CNS. J Neurosci 18 (1998) 3620-3629
52. Riikonen R. Neurotrophic factors in the pathogenesis of Rett syndrome. J Child Neurol 18 (2003) 693-697
53. Rockenstein E., Adame A., Mante M., Moessler H., Windisch M., and Masliah E. The neuroprotective effects of Cerebrolysin in a transgenic model of Alzheimer disease are associated with improved behavioral performance. J Neural Transm 110 (2003) 1313-1327
54. Roy N.S., Wang S., Jiang L., Kang J., Benraiss A., Harrison-Restelli C., et al. In vitro neurogenesis by progenitor cells isolated from the adult human hippocampus. Nat Med 6 (2000) 271-277
55. Ru{combining double acute accent}ther E., Ritter R., Apecechea M., Freytg S., Gmeinbauer R., and Windisch M. Sustained improvements in patients with dementia of Alzheimer type (DAT) 6 months after termination of Cerebrolysin therapy. J Neural Transm 107 (2000) 815-829
56. Shetty A.K., Hattiangady B., and Shetty G.A. Stem/progenitor cell proliferation factors FGF-2, IGF-1 and VEGF exhibit early decline during the course of aging in the hippocampus: role of astrocytes. Glia 51 (2005) 173-186
57. Shors T.J. Memory traces of trace memories: neurogenesis, synaptogenesis and awareness. Trends Neurosci 27 (2004) 250-256
58. Snyder J.S., Hong N.S., McDonald R.J., and Wojtowicz J.M. A role for adult neurogenesis in spatial long-term memory. Neuroscience 130 (2005) 843-852
59. Stopa E.G., Gonzalez A.M., Chorsky R., Corona R.J., Alzarez J., Bird E.D., et al. Basic fibroblast growth factor in Alzheimer disease. Biochem Biophys Res Commun 171 (1990) 690-696
60. Takami K., Matsuo A., Terai K., Walker D.G., McGeer E.G., and McGeer P.L. Fibroblast growth factor receptor-1 expression in the cortex and hippocampus in Alzheimer disease. Brain Res 802 (1998) 89-97
61. Tanaka Y., Kawahata K., Nakata T., and Hirokawa N. Chronological expression of microtubule-associated proteins (MAPs) in EC cell P19 after neuronal induction by retinoic acid. Brain Res 596 (1992) 269-278
62. Tatebayashi Y., Iqbal K., and Grundke-Iqbal I. Dynamic regulation of expression and phosphorylation of tau by fibroblast growth factor-2 in neural progenitor cells from adult rat hippocampus. J Neurosci 19 (1999) 5245-5254
63. Tatebayashi Y., Lee M.H., Li L., Iqbal K., and Grundke-Iqbal I. The dentate gyrus neurogenesis: a therapeutic target for Alzheimer disease. Acta Neuropathol (Berl) 105 (2003) 225-232
64. Tham A., Nordberg A., Grissom F.E., Carlsson-Skwirut C., Viitanen M., and Sara V.R. Insulin-like growth factors and insulin-like growth factor binding proteins in cerebrospinal fluid and serum of patients with dementia of the Alzheimer type. J Neural Transm Park Dis Dement Sect 5 (1993) 165-176
65. Vanhala R., Turpeinen U., and Riikonen R. Low levels of insulin-like growth factor-I in cerebrospinal fluid in children with autism. Dev Med Child Neurol 43 (2001) 614-616
66. Yasuhara T., Shingo T., Muraoka K., Kobayashi K., Takeuchi A., Yano A., et al. Early transplantation of an encapsulated glial cell line-derived neurotrophic factor-producing cell demonstrating strong neuroprotective effects in a rat model of Parkinsonism disease. J Neurosurg 102 (2005) 80-89
67. Ye J., Cao L., Cui R., Huang A., Yan Z., Lu C., et al. The effects of ciliary neurotrophic factor on neurological function and glial activity following contusive spinal cord injury in rats. Brain Res 997 (2004) 30-39
68. Zala D., Bensadoun J.-C., de Almeida L.P., Leavitt B.R., Gutekunst C.A., Aebischer P., et al. Long-term lentiviral-mediated expression of ciliary neurotrophic factor in the striatum of Huntington's disease transgenic mice. Exp Neurol 185 (2004) 26-35